These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 13765499)
21. Prostatic enzymes and abnormal bleeding. SCOTT EV Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):50-5; discussion, 56-7. PubMed ID: 13274457 [No Abstract] [Full Text] [Related]
22. [Research on some aspects of hematic fibrinolysis in animals subjected to unilateral nephrectomy]. FILIPAZZI A; LOSAPIO M Riv Patol Clin; 1962 Mar; 17():77-82. PubMed ID: 13892862 [No Abstract] [Full Text] [Related]
23. [Syndrome of prostatic fibrinolysis; hemorrhagic syndrome produced by presence in the blood of proteolytic enzyme originating in prostatic carcinomatous tissue]. TAGNON H Acta Clin Belg; 1954; 9(2):99-115. PubMed ID: 13180146 [No Abstract] [Full Text] [Related]
24. [On a case of cancer of the prostate with bone metastases and fibrinolysis]. MARCHAL G; DUHAMEL G; LEROUX M; NIVET M; SAMAM M Sangre (Barc); 1959; 30():472-7. PubMed ID: 14420870 [No Abstract] [Full Text] [Related]
25. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS]. NIEWIAROWSKI S Pol Arch Med Wewn; 1964; 34():211-7. PubMed ID: 14151493 [No Abstract] [Full Text] [Related]
26. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. II. INHIBITORS OF PROTEOLYSIS AND FIBRINOLYSIS]. NIEWIAROWSKI S Pol Arch Med Wewn; 1964; 34():351-5. PubMed ID: 14159674 [No Abstract] [Full Text] [Related]
30. Intracerebral hemorrhages, fibrinolysis, and prostate carcinoma. Braun JS; Novak R; Torzewski M; Soehngen D J Neurol; 2002 Apr; 249(4):478-9. PubMed ID: 11967657 [No Abstract] [Full Text] [Related]
31. [ON SOME CONCLUSIONS IN THE EXPERIMENTAL AND CLINICAL STUDY OF FIBRINOLYSIS]. ANDREENKO GV Ter Arkh; 1963 Jul; 35():3-12. PubMed ID: 14077561 [No Abstract] [Full Text] [Related]
32. [PATHOLOGY CAUSED BY EXCESS OF FIBRINOLYSIN IN GYNECOLOGY]. PESCETTO G Minerva Med; 1964 Jun; 55():1757-61. PubMed ID: 14174698 [No Abstract] [Full Text] [Related]
33. LIPOPROTEINS AND FIBRINOLYSIS. HOWELL M Proc R Soc Med; 1964 Jul; 57(7):606-9. PubMed ID: 14178953 [No Abstract] [Full Text] [Related]
34. Coagulopathy, following medical therapy, for carcinoma of the prostate. Bern MM Hematology; 2005 Feb; 10(1):65-8. PubMed ID: 16019449 [TBL] [Abstract][Full Text] [Related]
36. [Daily oscillations and thrombogenic action of fibrinolysis]. KOWARZYK H; KOTSCHY M; GLOGOWSKA I Postepy Hig Med Dosw; 1959; 13():311-4. PubMed ID: 14411495 [No Abstract] [Full Text] [Related]
37. [60 YEARS OF FIBRINOLYSIS]. MARCHAL G Hemostase; 1963; 3():101-4. PubMed ID: 14050807 [No Abstract] [Full Text] [Related]
38. [USE OF A PHOTOMETRIC METHOD FOR THE STUDY OF COAGULATION AND FIBRINOLYSIS]. GRUENDLINGER J; BOUVIER CA Thromb Diath Haemorrh; 1964 Dec; 12():423-51. PubMed ID: 14254702 [No Abstract] [Full Text] [Related]
39. [FIBRINOLYSIS IN SUBJECTS WITH PROSTATIC DISEASES EVALUATED WITH THROMBOELASTOGRAPHY]. SORBOLI G; ARISI GA; SCOPPETTA FP Chir Patol Sper; 1964 Sep; 12():542-50. PubMed ID: 14329914 [No Abstract] [Full Text] [Related]
40. [Fibrinolysis as a diagnostic test for prostatic carcinoma]. Burchardt P; Marscek M Urologe; 1971 Nov; 10(6):300-2. PubMed ID: 5137517 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]